• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有显著淋巴间质的爱泼斯坦-巴尔病毒相关鼻咽癌中免疫调节分子的表达。上皮肿瘤细胞与浸润性淋巴细胞之间功能相互作用的证据。

Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.

作者信息

Agathanggelou A, Niedobitek G, Chen R, Nicholls J, Yin W, Young L S

机构信息

Department of Pathology, University of Birmingham, United Kingdom.

出版信息

Am J Pathol. 1995 Oct;147(4):1152-60.

PMID:7573360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1871000/
Abstract

Undifferentiated nasopharyngeal carcinomas (UNPC) are characterized by an association with Epstein-Barr virus and an abundant lymphoid stroma. The role of this lymphoid stroma is uncertain but is mostly thought to represent an immune response against viral or tumor antigens. We have analyzed the expression of immune regulatory receptor/ligand pairs in snap-frozen biopsies of 20 UNPCs. All cases were Epstein-Barr virus positive and the virus-encoded latent membrane protein, LMP1, was expressed in 6 cases. By immunohistochemistry, we have demonstrated the expression of CD70 and CD40 in the tumor cells of 16 and 18 cases, respectively. Infiltrating lymphoid cells expressing CD27, the CD70 receptor, and the CD40 ligand were present in all cases. The Bcl-2 protein was detected in 17 cases. Unexpectedly, tumor cells of 5 cases expressed at least one member of the B7 family (CD80, CD86, and B7-3) and many lymphoid cells expressing the corresponding counter-receptor, CD28, were detected in all cases. Interestingly, 5 of 6 LMP1-positive cases also expressed B7, whereas all 14 LMP1-negative cases were also B7 negative. Our results indicate that T cells and carcinoma cells communicate in the microenvironment of UNPCs and suggest that the presence of a lymphoid stroma may be a requirement for UNPC growth at least in certain stages of tumor development.

摘要

未分化鼻咽癌(UNPC)的特征是与爱泼斯坦-巴尔病毒相关联且伴有丰富的淋巴样基质。这种淋巴样基质的作用尚不确定,但大多认为它代表了针对病毒或肿瘤抗原的免疫反应。我们分析了20例未分化鼻咽癌冰冻活检组织中免疫调节受体/配体对的表达情况。所有病例均为爱泼斯坦-巴尔病毒阳性,其中6例表达病毒编码的潜伏膜蛋白LMP1。通过免疫组织化学,我们分别在16例和18例肿瘤细胞中证实了CD70和CD40的表达。所有病例中均存在表达CD27(CD70受体)和CD40配体的浸润性淋巴细胞。在17例中检测到了Bcl-2蛋白。出乎意料的是,5例肿瘤细胞表达了B7家族的至少一个成员(CD80、CD86和B7-3),并且在所有病例中均检测到许多表达相应共受体CD28的淋巴细胞。有趣的是,6例LMP1阳性病例中有5例也表达B7,而所有14例LMP1阴性病例也均为B7阴性。我们的结果表明,T细胞与癌细胞在未分化鼻咽癌的微环境中相互作用,提示淋巴样基质的存在可能是未分化鼻咽癌生长的必要条件,至少在肿瘤发展的某些阶段是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/b9f9e20697cb/amjpathol00046-0292-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/210127bd7f7b/amjpathol00046-0288-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/cf2a7813c229/amjpathol00046-0289-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/7e760da08370/amjpathol00046-0290-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/0f542ec00b92/amjpathol00046-0291-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/b9f9e20697cb/amjpathol00046-0292-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/210127bd7f7b/amjpathol00046-0288-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/cf2a7813c229/amjpathol00046-0289-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/7e760da08370/amjpathol00046-0290-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/0f542ec00b92/amjpathol00046-0291-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089d/1871000/b9f9e20697cb/amjpathol00046-0292-a.jpg

相似文献

1
Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.具有显著淋巴间质的爱泼斯坦-巴尔病毒相关鼻咽癌中免疫调节分子的表达。上皮肿瘤细胞与浸润性淋巴细胞之间功能相互作用的证据。
Am J Pathol. 1995 Oct;147(4):1152-60.
2
Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.鼻咽癌前驱病变中的爱泼斯坦-巴尔病毒感染
Ai Zheng. 2006 Feb;25(2):136-42.
3
Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas.爱泼斯坦-巴尔病毒基因及淋巴细胞活化分子在未分化鼻咽癌中的表达
Am J Pathol. 1992 Apr;140(4):879-87.
4
Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation.
Cancer Res. 1999 Feb 15;59(4):924-30.
5
Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.爱泼斯坦-巴尔病毒相关的儿童鼻咽癌:其与p53和bcl-2表达的相关性
Med Pediatr Oncol. 2002 May;38(5):345-8. doi: 10.1002/mpo.1349.
6
Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.爱泼斯坦-巴尔病毒潜伏膜蛋白1通过影响细胞凋亡来调节胃癌细胞的恶性潜能。
Am J Pathol. 1998 Jan;152(1):63-74.
7
Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.爱泼斯坦-巴尔病毒感染与鼻咽癌的发病机制:病毒基因表达、肿瘤细胞表型及淋巴样基质的作用
Semin Cancer Biol. 1996 Aug;7(4):165-74. doi: 10.1006/scbi.1996.0023.
8
Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma.干扰素诱导趋化因子IP-10(CXCL10)在霍奇金淋巴瘤和鼻咽癌中的表达,IP-10是一种具有抗肿瘤功能的趋化因子。
J Pathol. 2005 May;206(1):68-75. doi: 10.1002/path.1745.
9
Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒编码RNA的表达作为转移性未分化鼻咽癌的标志物
Cancer. 1996 Jul 1;78(1):24-9. doi: 10.1002/(SICI)1097-0142(19960701)78:1<24::AID-CNCR5>3.0.CO;2-H.
10
Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.在爱泼斯坦-巴尔病毒感染的鼻咽癌细胞和活检组织中检测源自两个病毒启动子(Cp和Wp)的转录本。
Lab Invest. 1998 Jun;78(6):715-26.

引用本文的文献

1
The growing interests in Epstein-Barr virus: A bibliometric analysis of research trends, collaborations, and emerging hotspots.对爱泼斯坦-巴尔病毒日益增长的兴趣:研究趋势、合作及新兴热点的文献计量分析
Infect Med (Beijing). 2025 Jun 22;4(3):100194. doi: 10.1016/j.imj.2025.100194. eCollection 2025 Sep.
2
The Pan-Cancer Analysis Uncovers the Prognostic and Immunotherapeutic Significance of CD19 as an Immune Marker in Tumor.泛癌分析揭示了CD19作为肿瘤免疫标志物的预后和免疫治疗意义。
Int J Gen Med. 2024 Jun 4;17:2593-2612. doi: 10.2147/IJGM.S459914. eCollection 2024.
3
The development of chimeric antigen receptor T-cells against CD70 for renal cell carcinoma treatment.

本文引用的文献

1
A histological classification of carcinomas of the nasopharynx with a critical review as to the existence of lymphoepitheliomas.鼻咽癌的组织学分类及对淋巴上皮瘤存在与否的批判性综述
Cancer. 1962 Sep-Oct;15:895-920. doi: 10.1002/1097-0142(196209/10)15:5<895::aid-cncr2820150505>3.0.co;2-r.
2
The role of the CD28 receptor during T cell responses to antigen.CD28受体在T细胞对抗原反应过程中的作用。
Annu Rev Immunol. 1993;11:191-212. doi: 10.1146/annurev.iy.11.040193.001203.
3
Uterine cervical lymphoepithelial-like carcinoma. Absence of Epstein-Barr virus genomes.
嵌合抗原受体 T 细胞针对肾细胞癌治疗的 CD70 的开发。
J Transl Med. 2024 Apr 18;22(1):368. doi: 10.1186/s12967-024-05101-1.
4
Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.可溶性 CD27 作为鼻咽癌肿瘤内 CD70/CD27 相互作用的预测性生物标志物。
Cancer Sci. 2024 Apr;115(4):1073-1084. doi: 10.1111/cas.16079. Epub 2024 Jan 27.
5
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma.评估爱泼斯坦-巴尔病毒感染临床意义的最新进展及其在鼻咽癌诊断和治疗中的应用
Microorganisms. 2023 Dec 20;12(1):14. doi: 10.3390/microorganisms12010014.
6
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.新型高亲和力人源化抗体IMM40H靶向CD70,通过Fc介导的效应功能消除肿瘤,并中断CD70/CD27信号传导。
Front Oncol. 2023 Oct 2;13:1240061. doi: 10.3389/fonc.2023.1240061. eCollection 2023.
7
Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome.免疫检查点是骨髓增生异常综合征靶向治疗和预后方面一项很有前景的突破。
Heliyon. 2023 Sep 9;9(9):e19222. doi: 10.1016/j.heliyon.2023.e19222. eCollection 2023 Sep.
8
Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period.15 年间鼻咽癌免疫治疗试验的特点。
Front Immunol. 2023 Aug 9;14:1195659. doi: 10.3389/fimmu.2023.1195659. eCollection 2023.
9
Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review).鼻咽癌的免疫治疗:现状与展望(综述)。
Int J Oncol. 2023 Aug;63(2). doi: 10.3892/ijo.2023.5545. Epub 2023 Jul 7.
10
Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction.鼻咽癌细胞通过 CD70-CD27 相互作用促进调节性 T 细胞的发育和抑制活性。
Nat Commun. 2023 Apr 6;14(1):1912. doi: 10.1038/s41467-023-37614-6.
Am J Clin Pathol. 1993 Feb;99(2):195-9. doi: 10.1093/ajcp/99.2.195.
4
Epstein-Barr virus and CD30+ malignant lymphomas.
Crit Rev Oncog. 1993;4(2):191-239.
5
Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma.Bcl-2原癌基因在爱泼斯坦-巴尔病毒相关鼻咽癌中的表达。
Int J Cancer. 1993 Jan 2;53(1):29-35. doi: 10.1002/ijc.2910530107.
6
CD70 represents the human ligand for CD27.CD70是CD27的人类配体。
Int Immunol. 1994 Mar;6(3):477-80. doi: 10.1093/intimm/6.3.477.
7
The cloning of CD70 and its identification as the ligand for CD27.CD70的克隆及其作为CD27配体的鉴定。
J Immunol. 1994 Feb 15;152(4):1756-61.
8
Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction.CD40配体对正常和肿瘤性人类B淋巴细胞凋亡的抑制作用与Bcl-2的诱导无关。
Eur J Immunol. 1993 Sep;23(9):2368-71. doi: 10.1002/eji.1830230948.
9
CD27: marker and mediator of T-cell activation?
Immunol Today. 1994 Jul;15(7):307-11. doi: 10.1016/0167-5699(94)90077-9.
10
T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.辅助性T淋巴细胞上的T-BAM/CD40-L增强淋巴因子诱导的B细胞免疫球蛋白同种型转换重组,并使B细胞免于程序性细胞死亡。
J Immunol. 1994 Mar 1;152(5):2163-71.